LVAD İmplantasyonu Yapılan Hastada ICD Endikasyonu ve Yönetimi

Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997-4126. doi:10.1093/eurheartj/ehac262

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [published correction appears in Eur Heart J. 2021 Oct 14;:]. Eur Heart J. 2021;42(36):3599-3726. doi:10.1093/eurheartj/ehab368

Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e876-e894. doi:10.1161/CIR.0000000000001062

Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons [published correction appears in J Am Coll Cardiol. 2009 Apr 21;53(16):1473] [published correction appears in J Am Coll Cardiol. 2009 Jan 6;53(1):147]. J Am Coll Cardiol. 2008;51(21):e1-e62. doi:10.1016/j.jacc.2008.02.032

Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793-2867. doi:10.1093/eurheartj/ehv316

Nishimura M, Ogiwara M, Ishikawa M, et al. Fifteen-month circulatory support for sustained ventricular fibrillation by left ventricular assist device. J Thorac Cardiovasc Surg. 2003;126(4):1190-1192. doi:10.1016/s0022-5223(03)00726-8

Sims DB, Rosner G, Uriel N, González-Costello J, Ehlert FA, Jorde UP. Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device. Pacing Clin Electrophysiol. 2012;35(5):e144-e148. doi:10.1111/j.1540-8159.2011.03159.x

Felix SE, Martina JR, Kirkels JH, et al. Continuous-flow left ventricular assist device support in patients with advanced heart failure: points of interest for the daily management. Eur J Heart Fail. 2012;14(4):351-356. doi:10.1093/eurjhf/hfs012

Oz MC, Rose EA, Slater J, Kuiper JJ, Catanese KA, Levin HR. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol. 1994;24(7):1688-1691. doi:10.1016/0735-1097(94)90175-9

Feldman D, Pamboukian SV, Teuteberg JJ, et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32(2):157-187. doi:10.1016/j.healun.2012.09.013

Vakil K, Duval S, Cogswell R, et al. Impact of Implantable Cardioverter-Defibrillators on Waitlist Mortality Among Patients Awaiting Heart Transplantation: An UNOS/OPTN Analysis. JACC Clin Electrophysiol. 2017;3(1):33-40. doi:10.1016/j.jacep.2016.07.010

Cantillon DJ, Tarakji KG, Kumbhani DJ, Smedira NG, Starling RC, Wilkoff BL. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm. 2010;7(4):466-471. doi:10.1016/j.hrthm.2009.12.022

Refaat MM, Tanaka T, Kormos RL, et al. Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients. J Card Fail. 2012;18(2):140-145. doi:10.1016/j.cardfail.2011.10.020

Clerkin KJ, Topkara VK, Demmer RT, et al. Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry. JACC Heart Fail. 2017;5(12):916-926. doi:10.1016/j.jchf.2017.08.014

Vakil K, Kazmirczak F, Sathnur N, et al. Implantable Cardioverter-Defibrillator Use in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis. JACC Heart Fail. 2016;4(10):772-779. doi:10.1016/j.jchf.2016.05.003

Clerkin KJ, Topkara VK, Mancini DM, et al. The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: A propensity score matched analysis. J Heart Lung Transplant. 2017;36(6):633-639. doi:10.1016/j.healun.2016.11.008

Alvarez PA, Sperry BW, Pérez AL, et al. Implantable Cardioverter Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices: Utilization Patterns, Related Procedures, and Complications. J Am Heart Assoc. 2019;8(14):e011813. doi:10.1161/JAHA.118.011813

Gopinathannair R, Cornwell WK, Dukes JW, et al. Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association. Circulation. 2019;139(20):e967-e989. doi:10.1161/CIR.0000000000000673

Farrar DJ, Hill JD, Gray LA Jr, Galbraith TA, Chow E, Hershon JJ. Successful biventricular circulatory support as a bridge to cardiac transplantation during prolonged ventricular fibrillation and asystole. Circulation. 1989;80(5 Pt 2):III147-III151.

Maradey JA, Singleton MJ, O'Neill TJ, Bhave PD. Management of ventricular arrhythmias in patients with LVAD. Curr Opin Cardiol. 2020;35(3):289-294. doi:10.1097/HCO.0000000000000730

Moss JD. Early Ventricular Arrhythmias After LVAD: Prognostic Clue or Proximate Cause of Mortality?. JACC Clin Electrophysiol. 2019;5(8):955-957. doi:10.1016/j.jacep.2019.05.023

Shi J, Yu X, Liu Z. A Review of New-Onset Ventricular Arrhythmia after Left Ventricular Assist Device Implantation. Cardiology. 2022;147(3):315-327. doi:10.1159/000524779

Ambardekar AV, Lowery CM, Allen LA, et al. Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads. J Card Fail. 2010;16(4):327-331. doi:10.1016/j.cardfail.2009.12.003

Foo D, Walker BD, Kuchar DL, et al. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series. Pacing Clin Electrophysiol. 2009;32(7):879-887. doi:10.1111/j.1540-8159.2009.02403.x

Thomas IC, Cork DP, Levy A, et al. ICD lead parameters, performance, and adverse events following continuous-flow LVAD implantation. Pacing Clin Electrophysiol. 2014;37(4):464-472. doi:10.1111/pace.12290

Matthews JC, Betley D, Morady F, Pelosi F Jr. Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 2007;18(10):1107-1108. doi:10.1111/j.1540-8167.2007.00805.x

Netzler PC, Vasuki N, Peura JL, Gold MR. Interactions between a left ventricular assist device and implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2012;35(9):e272-e273. doi:10.1111/j.1540-8159.2012.03370.x

Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device [published correction appears in N Engl J Med. 2018 Aug 16;379(7):697]. N Engl J Med. 2009;361(23):2241-2251. doi:10.1056/NEJMoa0909938

Ahmed A, Amin M, Boilson BA, Killu AM, Madhavan M. Ventricular Arrhythmias in Patients With Left Ventricular Assist Device (LVAD). Curr Treat Options Cardiovasc Med. 2019;21(11):75. Published 2019 Nov 27. doi:10.1007/s11936-019-0783-7

Schron EB, Exner DV, Yao Q, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105(5):589-594. doi:10.1161/hc0502.103330

Gopinathannair R, Lerew DR, Cross NJ, Sears SF, Brown S, Olshansky B. Longitudinal changes in quality of life following ICD implant and the impact of age, gender, and ICD shocks: observations from the INTRINSIC RV trial. J Interv Card Electrophysiol. 2017;48(3):291-298. doi:10.1007/s10840-017-0233-y

Oswald H, Schultz-Wildelau C, Gardiwal A, et al. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail. 2010;12(6):593-599. doi:10.1093/eurjhf/hfq048

Galand V, Leclercq C, Bourenane H, et al. Implantable cardiac defibrillator leads dysfunction after LVAD implantation. Pacing Clin Electrophysiol. 2020;43(11):1309-1317. doi:10.1111/pace.14004

Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997-4126. doi:10.1093/eurheartj/ehac262

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [published correction appears in Eur Heart J. 2021 Oct 14;:]. Eur Heart J. 2021;42(36):3599-3726. doi:10.1093/eurheartj/ehab368

Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e876-e894. doi:10.1161/CIR.0000000000001062

Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons [published correction appears in J Am Coll Cardiol. 2009 Apr 21;53(16):1473] [published correction appears in J Am Coll Cardiol. 2009 Jan 6;53(1):147]. J Am Coll Cardiol. 2008;51(21):e1-e62. doi:10.1016/j.jacc.2008.02.032

Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793-2867. doi:10.1093/eurheartj/ehv316

Nishimura M, Ogiwara M, Ishikawa M, et al. Fifteen-month circulatory support for sustained ventricular fibrillation by left ventricular assist device. J Thorac Cardiovasc Surg. 2003;126(4):1190-1192. doi:10.1016/s0022-5223(03)00726-8

Sims DB, Rosner G, Uriel N, González-Costello J, Ehlert FA, Jorde UP. Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device. Pacing Clin Electrophysiol. 2012;35(5):e144-e148. doi:10.1111/j.1540-8159.2011.03159.x

Felix SE, Martina JR, Kirkels JH, et al. Continuous-flow left ventricular assist device support in patients with advanced heart failure: points of interest for the daily management. Eur J Heart Fail. 2012;14(4):351-356. doi:10.1093/eurjhf/hfs012

Oz MC, Rose EA, Slater J, Kuiper JJ, Catanese KA, Levin HR. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol. 1994;24(7):1688-1691. doi:10.1016/0735-1097(94)90175-9

Feldman D, Pamboukian SV, Teuteberg JJ, et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32(2):157-187. doi:10.1016/j.healun.2012.09.013

Vakil K, Duval S, Cogswell R, et al. Impact of Implantable Cardioverter-Defibrillators on Waitlist Mortality Among Patients Awaiting Heart Transplantation: An UNOS/OPTN Analysis. JACC Clin Electrophysiol. 2017;3(1):33-40. doi:10.1016/j.jacep.2016.07.010

Cantillon DJ, Tarakji KG, Kumbhani DJ, Smedira NG, Starling RC, Wilkoff BL. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm. 2010;7(4):466-471. doi:10.1016/j.hrthm.2009.12.022

Refaat MM, Tanaka T, Kormos RL, et al. Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients. J Card Fail. 2012;18(2):140-145. doi:10.1016/j.cardfail.2011.10.020

Clerkin KJ, Topkara VK, Demmer RT, et al. Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry. JACC Heart Fail. 2017;5(12):916-926. doi:10.1016/j.jchf.2017.08.014

Vakil K, Kazmirczak F, Sathnur N, et al. Implantable Cardioverter-Defibrillator Use in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis. JACC Heart Fail. 2016;4(10):772-779. doi:10.1016/j.jchf.2016.05.003

Clerkin KJ, Topkara VK, Mancini DM, et al. The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: A propensity score matched analysis. J Heart Lung Transplant. 2017;36(6):633-639. doi:10.1016/j.healun.2016.11.008

Alvarez PA, Sperry BW, Pérez AL, et al. Implantable Cardioverter Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices: Utilization Patterns, Related Procedures, and Complications. J Am Heart Assoc. 2019;8(14):e011813. doi:10.1161/JAHA.118.011813

Gopinathannair R, Cornwell WK, Dukes JW, et al. Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association. Circulation. 2019;139(20):e967-e989. doi:10.1161/CIR.0000000000000673

Farrar DJ, Hill JD, Gray LA Jr, Galbraith TA, Chow E, Hershon JJ. Successful biventricular circulatory support as a bridge to cardiac transplantation during prolonged ventricular fibrillation and asystole. Circulation. 1989;80(5 Pt 2):III147-III151.

Maradey JA, Singleton MJ, O'Neill TJ, Bhave PD. Management of ventricular arrhythmias in patients with LVAD. Curr Opin Cardiol. 2020;35(3):289-294. doi:10.1097/HCO.0000000000000730

Moss JD. Early Ventricular Arrhythmias After LVAD: Prognostic Clue or Proximate Cause of Mortality?. JACC Clin Electrophysiol. 2019;5(8):955-957. doi:10.1016/j.jacep.2019.05.023

Shi J, Yu X, Liu Z. A Review of New-Onset Ventricular Arrhythmia after Left Ventricular Assist Device Implantation. Cardiology. 2022;147(3):315-327. doi:10.1159/000524779

Ambardekar AV, Lowery CM, Allen LA, et al. Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads. J Card Fail. 2010;16(4):327-331. doi:10.1016/j.cardfail.2009.12.003

Foo D, Walker BD, Kuchar DL, et al. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series. Pacing Clin Electrophysiol. 2009;32(7):879-887. doi:10.1111/j.1540-8159.2009.02403.x

Thomas IC, Cork DP, Levy A, et al. ICD lead parameters, performance, and adverse events following continuous-flow LVAD implantation. Pacing Clin Electrophysiol. 2014;37(4):464-472. doi:10.1111/pace.12290

Matthews JC, Betley D, Morady F, Pelosi F Jr. Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 2007;18(10):1107-1108. doi:10.1111/j.1540-8167.2007.00805.x

Netzler PC, Vasuki N, Peura JL, Gold MR. Interactions between a left ventricular assist device and implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2012;35(9):e272-e273. doi:10.1111/j.1540-8159.2012.03370.x

Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device [published correction appears in N Engl J Med. 2018 Aug 16;379(7):697]. N Engl J Med. 2009;361(23):2241-2251. doi:10.1056/NEJMoa0909938

Ahmed A, Amin M, Boilson BA, Killu AM, Madhavan M. Ventricular Arrhythmias in Patients With Left Ventricular Assist Device (LVAD). Curr Treat Options Cardiovasc Med. 2019;21(11):75. Published 2019 Nov 27. doi:10.1007/s11936-019-0783-7

Schron EB, Exner DV, Yao Q, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105(5):589-594. doi:10.1161/hc0502.103330

Gopinathannair R, Lerew DR, Cross NJ, Sears SF, Brown S, Olshansky B. Longitudinal changes in quality of life following ICD implant and the impact of age, gender, and ICD shocks: observations from the INTRINSIC RV trial. J Interv Card Electrophysiol. 2017;48(3):291-298. doi:10.1007/s10840-017-0233-y

Oswald H, Schultz-Wildelau C, Gardiwal A, et al. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail. 2010;12(6):593-599. doi:10.1093/eurjhf/hfq048

Galand V, Leclercq C, Bourenane H, et al. Implantable cardiac defibrillator leads dysfunction after LVAD implantation. Pacing Clin Electrophysiol. 2020;43(11):1309-1317. doi:10.1111/pace.14004